Literature DB >> 11342313

Association of Burkitt's lymphoma with the Epstein-Barr virus in two developing countries.

C R Rao1, M I Gutierrez, K Bhatia, F Fend, J Franklin, L Appaji, G Gallo, G O'Conor, N Lalitha, I Magrath.   

Abstract

The clinical presentation of Burkitt's lymphoma (BL) and it's association with the Epstein-Barr virus (EBV) varies in different geographic areas, BL in developing countries being "intermediate" between the sporadic and endemic types, both in it's clinical presentation and it's association with EBV, which varies from 25-80%. In this study we have analysed the clinical features, EBV association, subtype and prevalence of the deleted variant of the Latent Membrane Protein-1 (LMP-1) of EBV in forty-two cases from two developing countries- India (n = 25) and Argentina (n = 17). In both countries the abdomen was the site most commonly involved while jaw involvement was rare. EBV was detected by in-situ hybridization using the EBER-1 RNA probe. 47% of cases from Argentina and 80% of cases from India were EBER positive. EBV typing using EBNA-3C primers showed a predominance of Type A in both countries (India-13/16 and Argentina-(7/8)). The 30bp deletion of the LMP-1 gene was detected in all evaluated cases from Argentina while the wild type of the gene was seen in all the evaluable Indian cases. Our study highlights the similarities and differences in the clinical presentation and EBV association of BL in two developing countries and also indicates that the subtype of EBV and prevalence of the LMP-1 deletion may reflect the predominant subtype in a particular population.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11342313     DOI: 10.3109/10428190009065832

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  6 in total

1.  Prognostic significance of cell proliferation and apoptosis-regulating proteins in Epstein-Barr Virus positive and negative pediatric non-Hodgkin's lymphoma.

Authors:  Safiye Aktaş; Aydanur Kargi; Nur Olgun; Gulden Diniz; Ayşe Erbay; Canan Vergin
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

2.  Sporadic Burkitt lymphomas of children and adolescents in Chinese: a clinicopathological study of 43 cases.

Authors:  Cheng-Feng Bi; Yuan Tang; Wen-Yan Zhang; Sha Zhao; Xiao-Qing Wang; Qun-Pei Yang; Gan-Di Li; Wei-ping Liu
Journal:  Diagn Pathol       Date:  2012-06-22       Impact factor: 2.644

3.  Epstein-Barr virus (EBV) detection and typing by PCR: a contribution to diagnostic screening of EBV-positive Burkitt's lymphoma.

Authors:  Rocío Hassan; Lídia Roxana White; Claudio Gustavo Stefanoff; Deilson Elgui de Oliveira; Fabricio E Felisbino; Claudete Esteves Klumb; Carlos E Bacchi; Héctor N Seuánez; Ilana R Zalcberg
Journal:  Diagn Pathol       Date:  2006-08-07       Impact factor: 2.644

4.  Identification of a novel variant of LMP-1 of EBV in patients with endemic Burkitt lymphoma in western Kenya.

Authors:  Eric M Wohlford; Amolo S Asito; Kiprotich Chelimo; Peter O Sumba; Paul C Baresel; Rebecca A Oot; Ann M Moormann; Rosemary Rochford
Journal:  Infect Agent Cancer       Date:  2013-09-09       Impact factor: 2.965

5.  Study of Epstein-Barr virus expression in Burkitt's lymphoma by polymerase chain reaction and in situ hybridization: A study in Iran.

Authors:  Parviz Deyhimi; Mahsa Kalantari
Journal:  Dent Res J (Isfahan)       Date:  2014-05

6.  Plasma Epstein-Barr virus and Hepatitis B virus in non-Hodgkin lymphomas: Two lymphotropic, potentially oncogenic, latently occurring DNA viruses.

Authors:  Mahua Sinha; Clementina Rama Rao; C S Premalata; Mohammed Shafiulla; K C Lakshmaiah; Linu Abraham Jacob; Govind K Babu; B K Viveka; L Appaji; Jayshree R Subramanyam
Journal:  Indian J Med Paediatr Oncol       Date:  2016 Jul-Sep
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.